Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This document outlines an ongoing Phase 1/2 dose-escalation and dose-expansion trial of MDX2003 in multiple lymphoma types, including Waldenström macroglobuline…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• High-grade B-cell Lymphoma
• Lymphoma
• Lymphoplasmacytic Lymphoma
• Mediastinal B-cell Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• MDX2003

Snippet

Sponsor: ModeX Therapeutics, An OPKO Health Company | Conditions: Lymphoma, Waldenström Macroglobulinemia (WM) | Phase 1, Phase 2 | Status: RECRUITING